Background Image
Table of Contents Table of Contents
Previous Page  381 / 1266 Next Page
Information
Show Menu
Previous Page 381 / 1266 Next Page
Page Background

62% of EGFRvIII patients

MGMT unmethylated

ACT IV phase III

randomised controlled trial

completed recruitment

very rapidly